2052
T. García et al. / Polymer 53 (2012) 2049e2061
J ¼ 6.75 Hz); 4.05 (t, CH2, 2H, J ¼ 6.38 Hz); 6.99 (d, CH, 2H,
J ¼ 9.05 Hz); 7.62 (d, CH, 2H, J ¼ 8.83 Hz); 7.76 (d, CH, 2H,
J ¼ 8.81 Hz) and 7.90 (d, CH, 2H, J ¼ 9.05 Hz).
1719 (m, C]O stretch), 1601, 1491, 1468 (m, C]C ring stretch), 1287
(m, Ce(C]O)eO stretch), 1254 (m, CeOeC asym. stretch), 1164 (m,
OeCeC asym. stretch), 1012 (m, CeOeC sym. stretch), 851, 816 (m,
CeH out of plane bending). 13C NMR (75 MHz, CDCl3,
d
¼ ppm):
2.2.14. (E)-40-((4-(6-bromohexyloxy)phenyl)diazenyl)-4-(hexyloxy)
167.6, 161.9, 160.6, 152.1, 147, 140.5, 136.6, 133.1, 132.9, 132.2, 127.3,
125.3, 125, 123.4, 116.4, 114.8, 112.8, 102.7, 69.5, 68.3, 64.7, 32,
29.8, 29.7, 29.7, 29.6, 29.5, 29.4, 29.2, 29, 28.7, 26, 25.9, 25.8, 22.8,
18.4, 14.2.
biphenyl-3-carbonitrile. (CN6,6)
Orange solid (Yield: 83%). 1H NMR (300 MHz, CDCl3,
d
¼ ppm):
0.92 (t, CH3, 3H, J ¼ 7.03 Hz); 1.56e1.30 (m, CH2, 10H); 1.96e1.80 (m,
CH2, 6H); 3.44 (t, CH2, 2H, J ¼ 6.75 Hz); 4.05 (t, CH2, 2H, J ¼ 6.40 Hz);
4.12 (t, CH2, 2H, J ¼ 6.54 Hz); 7.02 (m, CH, 3H); 7.64 (m, CH, 2H); 7.80
(m, CH, 2H) and 7.94 (m, CH, 4H).
2.2.20. (E)-4-((40-(dodecyloxy)-30-methoxy-[1,10-biphenyl]-4-yl)
diazenyl)phenol. (OCH312,0)
This compound was prepared from 3 and 2d following the same
procedure as for compound CN10,6. The mesogen OCH312,0,
recrystallized from acetone, was obtained as an orange solid (Yield:
2.2.15. (E)-40-((4-(6-bromohexyloxy)phenyl)diazenyl)-4-
(dodecyloxy)biphenyl-3-carbonitrile. (CN12,6)
Orange solid (Yield: 70%). 1H NMR (300 MHz, CDCl3,
d
¼ ppm):
64%). 1H NMR (300 MHz, CDCl3,
d
¼ ppm): 0.83 (t, CH3, 3H,
0.88 (t, CH3, 3H, J ¼ 6.70 Hz); 1.58e1.20 (m, CH2, 22H); 1.96e1.80
(m, CH2, 6H); 3.44 (t, CH2, 2H, J ¼ 6.75 Hz); 4.06 (t, CH2, 2H,
J ¼ 6.38 Hz); 4.12 (t, CH2, 2H, J ¼ 6.55 Hz); 7.02 (m, CH, 3H); 7.64 (m,
CH, 2H); 7.80 (m, CH, 2H) and 7.94 (m, CH, 4H).
J ¼ 6.70 Hz); 1.5e1.10 (m, CH2, 18H); 1.82 (m, CH2, 2H); 3.91 (s, CH3,
3H); 4.02 (t, CH2, 2H, J ¼ 6.90 Hz); 6.98 (m, CH, 3H); 7.14 (m, CH,
2H); 7.64 (m, CH, 2H) and 7.84 (m, CH, 4H).
2.2.21. (E)-(4-((40-dodecyloxy)-30-methoxybiphenyl-4-yl)diazenyl)
phenyl)methacrylate. (MOCH312,0)
2.2.16. (E)-1-(4-(4-bromobutoxy)phenyl)-2-(40-(dodecyloxy)-30-
methoxybiphenyl-4-yl)diazene. (OCH312,4)
In a 100 mL two-neck round-bottom flask, 0.87 g (1.78 mmol) of
OCH312,0 and 40 mL of THF (freshly distilled) were introduced and
the mixture was cooled to T ¼ 0e5 ꢀC. Then 0.36 g (3.56 mmol) of
triethylamine and 0.24 g (2.30 mmol) of methacryloyl chloride
were added dropwise. The reaction temperature was allowed to
increase gradually up to room temperature and stirred overnight.
Then, 30 mL of CH2Cl2 and 30 mL of H2O were added and the
organic phase was separated from the aqueous phase; the organic
layer was subsequently washed with aqueous solutions of HCl 5%,
K2CO3 5% and finally with water until neutral pH. The organic layer
was dried with Na2SO4 and the solvent was evaporated. The
monomer MOCH312,0 (recrystallized from acetone) was obtained
Orange solid (Yield: 73%). 1H NMR (300 MHz, CDCl3,
d
¼ ppm):
0.88 (t, CH3, 3H, J ¼ 6.70 Hz); 1.56e1.16 (m, CH2, 18H); 2.2e1.80 (m,
CH2, 6H); 3.51 (t, CH2, 2H, J ¼ 6.49 Hz); 3.96 (s, CH3, 3H); 4.07 (m,
CH2, 4H); 6.98 (m, CH, 3H); 7.21 (m, CH, 2H); 7.69 (d, CH, 2H,
J ¼ 8.43 Hz) and 7.93 (m, CH, 4H).
2.2.17. (E)-1-(4-(6-bromohexyloxy)phenyl)-2-(40-(dodecyloxy)-30-
methoxybiphenyl-4-yl)diazene. (OCH312,6)
Orange solid (Yield: 86%). 1H NMR (300 MHz, CDCl3,
d
¼ ppm):
0.88 (t, CH3, 3H, J ¼ 6.74 Hz); 1.57e1.20 (m, CH2, 22H); 1.96e1.79 (m,
CH2, 6H); 3.44 (t, CH2, 2H, J ¼ 6.75 Hz); 3.96 (s, CH3, 3H); 4.05 (t,
CH2, 2H, J ¼ 6.32 Hz); 4.07 (t, CH2, 2H, J ¼ 6.88 Hz); 6.99 (m, CH, 3H);
7.20 (m, CH, 2H); 7.69 (d, CH, 2H, J ¼ 8.6 Hz) and 7.93 (m, CH, 4H).
as an orange solid (Yield: 77%). 1H NMR (300 MHz, CDCl3,
d
¼ ppm):
0.88 (t, CH3, 3H, J ¼ 6.71 Hz); 1.53e1.18 (m, 18H); 1.88 (m, 2H); 2.09
(dd, CH3, 3H, J ¼ 0.95, 1.47 Hz); 4.04 (s, CH3, 3H); 4.07 (t, CH2, 2H,
J ¼ 6.9 Hz); 5.8 (m, 1H, ¼CH); 6.40 (m, 1H, ¼CH); 6.97 (d, CH, 1H,
J ¼ 8.31 Hz); 7.18 (d, CH, 1H, J ¼ 2.08 Hz); 7.21 (dd, CH, 2H, J ¼ 2.14,
8.24 Hz); 7.29 (d, CH, 2H, J ¼ 9.03 Hz); 7.71 (d, CH, 2H, J ¼ 8.82 Hz)
and 7.98 (m, CH, 4H). FTeIR (KBr, cmꢁ1) 2919 (s, nas CH2), 2852 (m,
ns CH2), 1742 (m, C]O stretch), 1592, 1493, 1467 (m, C]C ring
stretch), 1257 (m, CeOeC asym. stretch), 1202 (m, Ce(C]O)eO
stretch), 1151 (m, OeCeC asym. stretching), 1122 (m, OeCeC
asym. stretch), 1024 (m, CeOeC sym. stretch), 844, 802 (m, CeH
2.2.18. (E)-6-(4-((30-cyano-40-(hexyloxy)biphenyl-4-yl)diazenyl)
phenoxy)hexyl methacrylate. (MCN6,6)
Orange solid (Yield: 84%). 1H NMR (300 MHz, CDCl3,
d
¼ ppm):
0.92 (t, CH3, 3H, J ¼ 7.04 Hz); 1.60e1.3 (m, 10H); 1.93e1.68 (m, 6H);
1.94 (dd, CH3, 3H, J ¼ 0.71, 1.75 Hz); 4.05 (t, CH2, 2H, J ¼ 6.43 Hz);
4.12 (t, CH2, 2H, J ¼ 6.54 Hz); 4.17 (t, CH2, 2H, J ¼ 6.61 Hz); 5.55 (p,
1H, ]CH, J ¼ 1.61 Hz); 6.10 (m, 1H, ]CH); 7.00 (d, CH, 2H,
J ¼ 8.98 Hz); 7.04 (d, CH, 1H, J ¼ 8.87 Hz); 7.64 (d, 2H, J ¼ 8.44 Hz),
7.79 (dd, CH, 1H, J ¼ 2.38, 8.75 Hz), 7.84 (d, CH, 1H, J ¼ 2.35 Hz); 7.94
(dd, CH, 4H, J ¼ 6.94, 8.67 Hz). FTeIR (KBr, cmꢁ1) 2939 (s, nas CH2),
2869 (m, ns CH2), 2229 (w, CN stretch),1703 (m, C]O stretch),1603,
1490, 1475 (m, C]C ring stretch), 1278 (m, Ce(C]O)eO stretch),
1260 (m, CeOeC asym. stretch), 1174 (m, OeCeC asym. stretch),
1018 (m, CeOeC sym. stretch), 849, 818, 802 (m, CeH out of plane
out of plane bending). 13C NMR (75 MHz, CDCl3,
153, 151.4, 150.4, 149.8, 149, 143.8, 135.8, 133, 127.8, 127.4, 124.1,
123.5, 122.4, 119.8, 113.2, 110.9, 69.2, 55.3, 32, 29.8, 29.7, 29.7, 29.7,
29.5, 29.5, 29.3, 26.1, 22.8, 18.5, 14.2.
d
¼ ppm): 165.6,
2.2.22. (E)-4-(4-((40-(dodecyloxy)-30-methoxybiphenyl-4-yl)
bending). 13C NMR (75 MHz, CDCl3,
152.1, 147, 140.5, 136.6, 133.1, 132.9, 132.2, 127.3, 125.34, 125, 123.4,
116.4, 114.8, 112.8, 102.7, 69.5, 68.3, 64.7, 31.6, 29.2, 29, 28.7, 25.9,
25.8, 25.6, 22.6, 18.4, 14.1.
d
¼ ppm): 167.6, 161.9, 160.6,
diazenyl)phenoxy)butylmethacrylate. (MOCH312,4)
Orange solid (Yield: 89%). 1H NMR (300 MHz, CDCl3,
d
¼ ppm):
0.88 (t, CH3, 3H, J ¼ 6.65 Hz); 1.52e1.2 (m, 18H); 1.94e1.81 (m, 6H),
1.95 (m, 3H); 4.07 (t, CH2, 2H, J ¼ 6.95 Hz); 4.09 (t, CH2, 2H,
J ¼ 5.58 Hz); 4.25 (t, CH2, 2H, J ¼ 5.91 Hz); 5.56 (p, 1H, ]CH,
J ¼ 1.61 Hz); 6.12 (m, 1H, ]CH); 6.96 (d, CH, 1H, J ¼ 8.36 Hz); 7.01 (d,
CH, 2H, J ¼ 9.06 Hz); 7.19 (m, CH, 3H); 7.69 (d, 2H, J ¼ 8.74 Hz), 7.93
(dd, CH, 4H, J ¼ 3.68, 8.85 Hz). FTeIR (KBr, cmꢁ1) 2919 (s, nas CH2),
2852 (m, ns CH2), 1718 (m, C]O stretch), 1594, 1497, 1468 (m, C]C
ring stretch), 1255 (m, CeOeC asym. stretch), 1155 (m, OeCeC
asym. stretch), 1024 (m, CeOeC sym. stretch), 846, 805 (m, CeH
2.2.19. (E)-6-(4-((30-cyano-40-(dodecyloxy)biphenyl-4-yl)diazenyl)
phenoxy)hexyl methacrylate. (MCN12,6)
Orange solid (Yield: 62%). 1H NMR (300 MHz, CDCl3,
d
¼ ppm):
0.88 (t, CH3, 3H, J ¼ 6.5 Hz); 1.56e1.2 (m, 22H); 1.93e1.68 (m, 6H);
1.95 (dd, CH3, 3H, J ¼ 0.99, 1.58 Hz); 4.05 (t, CH2, 2H, J ¼ 6.42 Hz);
4.12 (t, CH2, 2H, J ¼ 6.55 Hz); 4.17 (t, CH2, 2H, J ¼ 6.6 Hz); 5.55 (p, 1H,
]CH, J ¼ 1.59, 1.60 Hz); 6.10 (qd, 1H, ]CH, J ¼ 0.96, 1.95 Hz); 7.02
(m, CH, 3H); 7.64 (m, 2H), 7.79 (dd, CH, 1H, J ¼ 2.40, 8.76 Hz), 7.84 (d,
CH, 1H, J ¼ 2.23 Hz) and 7.94 (dd, CH, 4H, J ¼ 6.97, 8.90 Hz). FTeIR
(KBr, cmꢁ1) 2924 (s, nas CH2), 2853 (m, ns CH2), 2227 (w, CN stretch),
out of plane bending). 13C NMR (75 MHz, CDCl3,
161.6, 151.5, 149.8, 148.9, 147.1, 143.1, 136.5, 133.1, 127.4, 125.5, 124.9,
123.2, 119.8, 114.8, 113.2, 110.9, 100, 69.2, 67.5, 64.4, 56.3, 32.0, 29.8,
29.7, 29.7, 29.7, 29.5, 29.5, 29.3, 26.1, 26, 25.5, 22.8, 18.4, 14.2.
d
¼ ppm): 167.5,